Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9801–9850 of 18658
On June 14, 2023, the sole Director of the Company, Mr Sytner, resolved to step down from his positions as Chief Executive Officer, President, Chief Financial Officer and Director of the Company, and for Mr. Xianchang Ma to be appointed as the Chief Executive Officer, President, Chief Financial Officer and Director of the Company.
On June 14, 2023, the sole Director of the Company, Mr Sytner, resolved to step down from his positions as Chief Executive Officer, President, Chief Financial Officer and Director of the Company, and for Mr. Xianchang Ma to be appointed as the Chief Executive Officer, President, Chief Financial Officer and Director of the Company.
the Company appointed Kevin A. Lansberry, age 59, to serve as the Company's Interim Chief Financial Officer and principal financial officer, effective July 1, 2023.
Ms. McCarthy will cease to serve as Senior Executive Vice President and Chief Financial Officer during her leave of absence and will have the title 'Strategic Advisor' during the leave.
On June 9, 2023, Robert Madore, Interim Chief Financial Officer of F45 Training Holdings Inc. (the “Company”), notified the Company that he would be resigning from his position as Interim Chief Financial Officer.
David Maday has been appointed as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer effective June 14, 2023
Richard Tame, who resigned as Chief Financial Officer on June 12, 2023 and will continue with the Company in a transitional role until August 31, 2023
appointed Jantoon Reigersman, the Company’s Chief Operating Officer, as the Company’s President and Chief Executive Officer, effective as of June 15, 2023
the Company terminated the employment of Michael Darrow as President and Chief Executive Officer of the Company
Pursuant to the Separation and Release Agreement, Ms. Sooch will receive certain benefits in connection with Ms. Sooch being terminated without cause on April 19, 2023.
Ankit Mahadevia, M.D., the Company’s Chief Executive Officer and President, determined to step down from that role, effective as of August 1, 2023
Satyavrat Shukla, the Company’s current Chief Financial Officer and Treasurer, was appointed by the Board to serve as Chief Executive Officer and President of the Company and as a member of the Board
Stephen J. DiPalma to be the Company’s Interim Chief Financial Officer and Treasurer to succeed Mr. Shukla
On June 14, 2023, Shoals Technologies Group, Inc. (the “Company”) announced that it has appointed Brandon Moss as Chief Executive Officer of the Company, effective as of July 17, 2023 (the “Effective Date”).
On June 9, 2023, the Board of Directors (the “Board”) of Five Below, Inc. (the “Company”) appointed Kristy Chipman as the Company’s Chief Financial Officer, effective on or about July 17, 2023.
the Company and Shaun Blakeman, the Company’s then Chief Financial Officer, agreed that Mr. Blakeman would no longer serve as the Company’s Chief Financial Officer.
On June 13, 2023, Isaac Kalish, a Senior Vice President, was appointed to serve also as our Chief Financial Officer ( i.e ., our principal financial officer), succeeding David W. Kalish in such position.
appointed Ayman Moussa as the Company’s Chief Executive Officer, to succeed Jeff Clementz
J. Kyle Derham resigned as the Company’s Chief Executive Officer and James Wilmot Rogers resigned as the Company’s Chief Financial Officer and Chief Accounting Officer.
J. Kyle Derham resigned as the Company’s Chief Executive Officer and James Wilmot Rogers resigned as the Company’s Chief Financial Officer and Chief Accounting Officer.
On June 14, 2023, HealthEquity, Inc. (the “Company”) announced that James M. Lucania will be appointed as the Company’s new Executive Vice President and Chief Financial Officer.
On June 12, 2023, Zikang Wu as the sole director of the Company, appointed Zikang Wu as Chief Executive Officer, effective June 12, 2023.
On June 12, 2023, effective immediately, the following officers and directors submitted the resignation of their respective offices: Simon Cottle, as director and Chief Executive Officer, Patrick Hargutt, as director and Chief Financial Officer, and each of James Brooks, Greg Caswill, Robert Piconi, Xavier Flinois and Elizabeth Weymouth as directors of the Company.
On June 12, 2023, effective immediately, the following officers and directors submitted the resignation of their respective offices: Simon Cottle, as director and Chief Executive Officer, Patrick Hargutt, as director and Chief Financial Officer, and each of James Brooks, Greg Caswill, Robert Piconi, Xavier Flinois and Elizabeth Weymouth as directors of the Company.
Marathon Digital Holdings, Inc. (the “Company”) appointed Salman Khan as its new Chief Financial Officer, effective as of June 14, 2023.
On June 12, 2023, George Chi was terminated for cause as an employee and Chief Financial Officer of OncoSec Medical Incorporated (the “Company”), effective immediately.
In addition to his resignation from the Company’s Board of Directors, Dr. Arch tendered his resignation as the Company’s President and Chief Executive Officer effective on June 14, 2023
On June 9, 2023, Eric Schmidt, Ph.D., the Chief Financial Officer, principal financial officer and principal accounting officer of Allogene Therapeutics, Inc. (the “Company”), notified the Company of his decision to resign, effective at the close of business on August 2, 2023, to spend more time with his family.
the Board appointed Daniel Virnich, the Company’s current President, as Chief Executive Officer effective as of June 30, 2023
On June 11, 2023, the Board of Directors (the “Board”) of Illumina, Inc. (the “Company”) accepted the resignation of Francis deSouza, which Mr. deSouza submitted to the Board on June 8, 2023, as Chief Executive Officer and as a director of the Company, effective immediately
the Board appointed Charles Dadswell, the Company’s current Senior Vice President and General Counsel, to serve as interim Chief Executive Officer, effective immediately
the Board appointed Guy Gecht, who has served as an independent member of Board, member of the Audit Committee of the Board, and member and Chairperson of its Technology and Innovation Committee, as Interim Chief Executive Officer of Logitech, effective immediately.
Bracken Darrell resigned from his position as the President and Chief Executive Officer of Logitech International S.A.
Beatriz Blanco would be ending her employment as President of and Chief Executive Officer of the Company. Ms. Blanco’s role as President and her involvement in the daily operations of the company were mutually terminated effective June 8, 2023
the Company entered into an Employment Agreement (the “Employment Agreement”) with Chris Jones, age 49, to serve as Chief Financial Officer of the Company, effective July 10, 2023
Michael Rabinovitch, Chief Financial Officer of BurgerFi International, Inc., a Delaware corporation (the “Company”), notified the Company that he is resigning from his positions with the Company effective no later than July 31, 2023
Brian Drazba’s employment as the CFO of the Company will terminate as of the closing date of the Merger, and in any event no later than September 1, 2023.
Christopher E. Jones, Odyssey’s chief financial officer, has resigned from the company effective July 7, 2023, to pursue another opportunity.
the Bank entered into an employment agreement, effective June 26, 2023 (the "Employment Agreement") with Jennings 'Jay' Walker as Chief Financial Officer.
Mark Murray intends to retire as the Company's President and Chief Executive Officer, effective June 23, 2023
the Board of Directors (the "Board") of the Company had appointed David Knight, age 59, to succeed Mr. Murray as the Company's President and Chief Executive Officer, effective June 23, 2023
appointed Chris Rivera, age 44, as the Company’s Interim Chief Financial Officer and as the Company’s Principal Financial Officer during Ms. Chan’s parental leave, effective June 26, 2023.
appointed Patty Chan as the Company’s Chief Financial Officer, effective June 12, 2023.
The following officer appointments for the Company are effective immediately and the officers shall hold such positions until their earlier resignation, removal or death, or until their successor is duly appointed and qualified. Ross Sklar Chief Executive Officer, President Darin Brown Chief Operating Officer, Secretary David Dreyer Chief Marketing Officer Kevin Zaccardi Interim-Chief Financial Officer, Treasurer
The following officer appointments for the Company are effective immediately and the officers shall hold such positions until their earlier resignation, removal or death, or until their successor is duly appointed and qualified. Ross Sklar Chief Executive Officer, President Darin Brown Chief Operating Officer, Secretary David Dreyer Chief Marketing Officer Kevin Zaccardi Interim-Chief Financial Officer, Treasurer
John Butler, the Company’s President and Chief Executive Officer, will act as interim principal financial officer and principal accounting officer from the Transition Date until the Effective Date.
On June 12, 2023 , the Company announced that Ellen Snow will succeed Mr. Spellman as the Company’s Senior Vice President, Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer, effective July 17, 2023 (the “Effective Date”).
On June 9, 2023, David A. Spellman, Senior Vice President, Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer of Akebia Therapeutics, Inc. (the “Company”), notified the Company of his intent to resign.
On June 6, 2023, Patrick J. Guido notified Chico’s FAS, Inc. (the “Company”) of his decision to resign from the Company as Executive Vice President and Chief Financial Officer, to accept a position at another company where he can be located closer to his family.
Mr. Guido will be succeeded by David M. Oliver, who has been appointed Executive Vice President, Chief Financial Officer and Chief Accounting Officer of the Company, effective June 24, 2023.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.